Genscript Biotech Corporation (GNNSF) Financials
GNNSF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 4.8 billion | 881.4 million |
| Dec. 31, 2025 | 4.9 billion | 876.3 million |
| June 30, 2025 | 5.4 billion | 1.0 billion |
| Dec. 31, 2024 | 5.3 billion | 954.9 million |
GNNSF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| Dec. 31, 2025 | 58.8 million | 5.2 million |
| June 30, 2025 | 200.5 million | 9.6 million |
| Dec. 31, 2024 | -18.1 million | 23.2 million |
GNNSF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | ? |
| Dec. 31, 2025 | -445.1 million |
| June 30, 2025 | -25.5 million |
| Dec. 31, 2024 | 3.0 billion |
GNNSF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 831.0 million | - | 51.5 million |
| Dec. 31, 2025 | 843.0 million | 85.9 million | 64.2 million |
| June 30, 2025 | 960.8 million | 329.9 million | 63.2 million |
| Dec. 31, 2024 | 621.2 million | 17.3 million | 64.5 million |
GNNSF Shares Outstanding
GNNSF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 39.3 million | 117.4 million | - |
| Dec. 31, 2025 | 44.0 million | 40.0 million | 116.7 million | - |
| June 30, 2025 | 32.1 million | 31.3 million | 110.2 million | 47.5 million |
| Dec. 31, 2024 | 13.9 million | -182.9 million | -18.9 million | -9.2 million |
GNNSF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 403.2 million | 197.0 million |
| Dec. 31, 2025 | 441.6 million | 208.6 million |
| June 30, 2025 | 518.8 million | 198.1 million |
| Dec. 31, 2024 | 33.1 million | 68.0 million |
GNNSF
Price: $3.70
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.25 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.0 billion